Vaccine Vials Market Research Report by Type, Material, Capacity, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Vaccine Vials Market Research Report by Type, Material, Capacity, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Vaccine Vials Market size was estimated at USD 514.72 million in 2021 and expected to reach USD 569.11 million in 2022, and is projected to grow at a CAGR 10.74% to reach USD 949.52 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Multi Dose and Single Dose.

Based on Material, the market was studied across Glass and Polymer.

Based on Capacity, the market was studied across 10ml, 20ml, 2ml, 3ml, and 5ml.

Based on Application, the market was studied across Preventive Vaccine and Therapeutic Vaccine.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vaccine Vials market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Vaccine Vials Market, including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the Global Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the Global Vaccine Vials Market?
6. What is the market share of the leading vendors in the Global Vaccine Vials Market?
7. What modes and strategic moves are considered suitable for entering the Global Vaccine Vials Market?

Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for a large number of vaccines for the sales of vaccine vials
5.1.1.2. High prevalence of infectious diseases and rise of pharmaceutical industries
5.1.1.3. Growing initiatives from government and private organizations to advance vaccination
5.1.2. Restraints
5.1.2.1. Lack of healthcare infrastructure in developing countries such as Brazil, India, and China
5.1.3. Opportunities
5.1.3.1. Rising awareness of immunization among the people regarding the endemic diseases
5.1.3.2. Development of innovative vaccine administration methods
5.1.3.3. Attractive investment in Vaccine vial monitor (VVM)
5.1.4. Challenges
5.1.4.1. High-cost associated with the supply chain of vaccine vials
5.2. Cumulative Impact of COVID-19
6. Vaccine Vials Market, by Type
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose
7. Vaccine Vials Market, by Material
7.1. Introduction
7.2. Glass
7.3. Polymer
8. Vaccine Vials Market, by Capacity
8.1. Introduction
8.2. 10ml
8.3. 20ml
8.4. 2ml
8.5. 3ml
8.6. 5ml
9. Vaccine Vials Market, by Application
9.1. Introduction
9.2. Preventive Vaccine
9.3. Therapeutic Vaccine
10. Americas Vaccine Vials Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Vaccine Vials Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Vaccine Vials Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Berlin Packaging LLC
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Cardinal Health, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Catalent, Inc.
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Corning Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. DWK Life Sciences GmbH
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Gerresheimer AG
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Jinan Youlyy Industrial Co., Ltd.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. JOTOP Glass
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Nipro Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Origin Pharmaceuticals Ltd
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Pacific Vial Manufacturing Inc.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Qorpak, Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. Richland Glass Company, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. SCHOTT AG
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. Shandong Pharmaceutical Glass Co., Ltd.
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. SiO2 Medical Products
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Stevanato Group
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. Thermo Fisher Scientific Inc
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Vetter Pharma-Fertigung GmbH & Co. KG.
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL VACCINE VIALS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VACCINE VIALS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL VACCINE VIALS MARKET DYNAMICS
FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2021 VS 2027 (%)
FIGURE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY MATERIAL, 2027
FIGURE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2018-2027 (USD MILLION)
FIGURE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2021 VS 2027 (%)
FIGURE 22. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY CAPACITY, 2027
FIGURE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2018-2027 (USD MILLION)
FIGURE 34. AMERICAS VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 36. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 37. AMERICAS VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 38. ARGENTINA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 39. BRAZIL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. CANADA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. MEXICO VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 45. UNITED STATES VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 46. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 47. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 49. ASIA-PACIFIC VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 50. AUSTRALIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. CHINA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. INDIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. INDONESIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. JAPAN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. MALAYSIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. PHILIPPINES VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. SINGAPORE VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. SOUTH KOREA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. TAIWAN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. THAILAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. VIETNAM VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 66. DENMARK VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. EGYPT VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. FINLAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. FRANCE VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. GERMANY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. ISRAEL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. ITALY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. NETHERLANDS VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. NIGERIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NORWAY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. POLAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. QATAR VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. RUSSIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. SAUDI ARABIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SOUTH AFRICA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SPAIN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SWEDEN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. SWITZERLAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. TURKEY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. UNITED KINGDOM VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. GLOBAL VACCINE VIALS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 88. GLOBAL VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 89. GLOBAL VACCINE VIALS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL VACCINE VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2021
TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. AMERICAS VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 44. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 45. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 46. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 47. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 48. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 49. ARGENTINA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 50. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 51. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 52. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 53. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 54. BRAZIL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 56. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 57. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 58. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 59. CANADA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 61. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 62. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 63. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 64. MEXICO VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 65. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 66. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 67. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 68. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 69. UNITED STATES VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 70. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 71. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 72. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 74. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 81. AUSTRALIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 82. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 83. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 84. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 85. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 86. CHINA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 87. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 88. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 89. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 90. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 91. INDIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 92. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 93. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 94. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 95. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 96. INDONESIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 97. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 98. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 99. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 100. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 101. JAPAN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 102. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 103. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 104. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 105. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 106. MALAYSIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 107. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 108. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 109. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 110. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 111. PHILIPPINES VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 112. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 113. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 114. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 115. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 116. SINGAPORE VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 117. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 118. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 119. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 120. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 121. SOUTH KOREA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 122. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 123. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 124. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 125. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 126. TAIWAN VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 128. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 129. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 130. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 131. THAILAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 133. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 134. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 135. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 136. VIETNAM VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 138. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 139. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 140. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 147. DENMARK VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 149. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 150. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 151. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 152. EGYPT VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 153. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 154. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 155. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 156. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 157. FINLAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 158. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 159. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 160. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 161. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 162. FRANCE VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 163. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 164. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 165. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 166. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 167. GERMANY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 168. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 169. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 170. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 171. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 172. ISRAEL VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 173. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 174. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 175. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 176. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 177. ITALY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 178. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 179. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 180. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 181. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 182. NETHERLANDS VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 183. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 184. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 185. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 186. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 187. NIGERIA VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 188. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 189. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 190. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 191. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 192. NORWAY VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 193. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 194. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)
TABLE 195. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2027 (USD MILLION)
TABLE 196. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 197. POLAND VACCINE VIALS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 198. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 199. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2027 (USD MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings